-
Study Presents Clinical, Genetic Landscape of Pompe Disease
-
A Doctor Tested a New Treatment on Himself, Now it's Saving Other Lives
-
His daughter has a rare disorder. He’s developing a novel gene therapy.
-
TRNDS Speaker Danielle Edwards, Jett Foundation
-
TRNDS Speaker Benjamin Schlatka, MC10
-
Forget Single Genes: CRISPR Now Cuts & Splices Whole Chromosomes
-
Gene Therapy Developers Issue Principles for Human Genome Editing
-
TRNDS Speaker Nancy Yu, RDMD
-
TRNDS Speaker Rachel McMinn, Neurogene
-
Gene Linked to Rare Neurological Disorder May Play a Role in Alzheimer’s
-
FDA Cancer Office Taps Syapse for Real-world Evidence Development
-
NIH All of Us Project Tops 270,000 Sign-ups
-
Meet TRNDS 2019 Speaker Traci Schilling, PTC Therapeutics
-
Netflix's Medical Investigation Docuseries 'Diagnosis'
-
Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome
-
Antisense Drugs for HD, ALS & Prion Could Meet the Need for Brain Treatments
-
'Dr. Google' Helps Some Patients Diagnose a Rare Disease
-
Evidation & Eli Lilly Study Uses Apple Devices, Apps to Predict Cognitive Impairment
-
HD Patients Prefer Less Invasive, No-Placebo Gene Therapy Trials
-
Meet TRNDS Speaker Tauna Batiste
-
C-Path and NORD Collaborate to Launch Rare Disease Data Platform
-
Neurogene Opens Natural History Study of CLN7, CLN5 Diseases at UT Southwestern
-
Rare Pediatric Disease PRVs: FDA Updates Guidance
-
Meet TRNDS 2019 Speaker PJ Brooks
Subscribe for TRNDS updates and rare disease news